March 19, 2013

Panel III: Perspectives on the Proposed HHS Framework on Funding HPAI H5N1 GOF Research

Day 1

2:15 -- 4:10 P.M. Panel III: Perspectives on the Proposed Framework for Guiding U.S. Department of Health and Human Services Funding Decisions about Highly Pathogenic Avian Influenza H5N1 Gain-of-Function Research

Special Presentation:

This presentation will introduce the proposed HHS Framework for guiding funding decisions about HPAI H5N1 GOF research. This panel will then discuss the proposed Framework within the context of their areas of expertise.

Amy P. Patterson, M.D.
Associate Director for Science Policy, National Institutes of Health, USA

Discussion Questions:

1. What are your perspectives on the proposed HHS Framework?
2. Are there any risks that are not addressed by the Framework, including those identified during the Panel II discussion?

Panel Co-Moderators:

Amy P. Patterson, M.D.
Associate Director for Science Policy, National Institutes of Health, USA

Samuel Stanley, M.D.
President, Stony Brook University, Chair, National Science Advisory Board for Biosecurity, USA

Panelists:

Daniel Altmann, Ph.D.
Head of Pathogens, Immunology and Population Health, Wellcome Trust, United Kingdom

Marianne Donker, Ph.D.
Director of Public Health, Ministry of Health, the Netherlands

Keith Hamilton, B.V.Sc., M.Sc., MRCVS
Scientific and Technical Department, World Organisation for Animal Health

Yoshihiro Kawaoka, D.V.M., Ph.D.
Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, USA

Zarifah Reed, M.D.
Medical Director, SENTINEXT Therapeutics, Malaysia

Michael Selgelid, Ph.D., M.A.
Senior Lecturer and Deputy Director, Centre for Human Bioethics, Monash University, Australia

David Swayne, D.V.M., Ph.D.
Southeast Poultry Research Laboratory, Agricultural Research Service, Department of Agriculture, USA